» Articles » PMID: 11964179

Expression and Characterization of the Active Molecular Forms of Choline/ethanolamine Kinase-alpha and -beta in Mouse Tissues, Including Carbon Tetrachloride-induced Liver

Overview
Journal Biochem J
Specialty Biochemistry
Date 2002 Apr 20
PMID 11964179
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Choline/ethanolamine kinase (ChoK/EtnK) exists as at least three isoforms (alpha1, alpha2 and beta) in mammalian cells. The physiological significance for the existence of more than one form of the enzyme, however, remains to be determined. In the present study, we examined the expression and distribution of the isoforms in mouse tissues using isoform-specific cDNA probes and polyclonal antibodies raised against each N-terminal peptide sequence. Both Northern- and Western-blot analyses indicated that either the alpha (alpha1 plus alpha2) or the beta isoform appeared to be the ubiquitously expressed enzyme. The mRNA abundance for the alpha isoform was highest in testis, whereas that for the beta isoform was relatively high in heart and liver. While the native form of each isoform was reported to consist of either homodimers or homotetramers, our immunotitration studies clearly indicated that a considerable part of the active form of the enzyme consists of alpha/beta hetero-oligomers, with relatively small parts of activity expressed by alpha/alpha and beta/beta homo-oligomers. This is the first experimental evidence for the presence of heteromeric ChoK/EtnK in any source. Thus our results strongly suggested that the activity of ChoK/EtnK in the cell is controlled not only by the level of each isoform but also by their combination to form the active oligomer complex. Carbon tetrachloride (CCl(4)) was shown to induce ChoK activity 2-4-fold in murine liver. Our analysis for the mechanism involved in this induction revealed that the responsible isoform for CCl(4) was alpha, not beta. The level of alpha mRNA was strongly induced in mouse liver, which resulted in a sustained increase in the amount of the alpha isoform. Consequently, the composition of alpha/alpha homo-oligomers came to represent up to 80% of the total active molecular form of ChoK in CCl(4)-induced liver, whereas it was less than 20% in normal uninduced liver.

Citing Articles

PCYT2 inhibits epithelial-mesenchymal transition in colorectal cancer by elevating YAP1 phosphorylation.

Zhou L, Zhang S, Wang L, Liu X, Yang X, Qiu L JCI Insight. 2024; 9(24).

PMID: 39531326 PMC: 11665560. DOI: 10.1172/jci.insight.178823.


Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases.

Lacal J, Zimmerman T, Campos J Pharmaceutics. 2021; 13(6).

PMID: 34070409 PMC: 8226952. DOI: 10.3390/pharmaceutics13060788.


Targeting Phospholipid Metabolism in Cancer.

Cheng M, Bhujwalla Z, Glunde K Front Oncol. 2017; 6:266.

PMID: 28083512 PMC: 5187387. DOI: 10.3389/fonc.2016.00266.


Phosphorylation of Human Choline Kinase Beta by Protein Kinase A: Its Impact on Activity and Inhibition.

Chang C, Few L, Konrad M, See Too W PLoS One. 2016; 11(5):e0154702.

PMID: 27149373 PMC: 4858151. DOI: 10.1371/journal.pone.0154702.


Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.

Arlauckas S, Popov A, James Delikatny E Prog Lipid Res. 2016; 63:28-40.

PMID: 27073147 PMC: 5360181. DOI: 10.1016/j.plipres.2016.03.005.


References
1.
Sipes I, el Sisi A, Sim W, Mobley S, Earnest D . Reactive oxygen species in the progression of CCl4-induced liver injury. Adv Exp Med Biol. 1991; 283:489-97. DOI: 10.1007/978-1-4684-5877-0_65. View

2.
Uchida T, Yamashita S . Purification and properties of choline kinase from rat brain. Biochim Biophys Acta. 1990; 1043(3):281-8. DOI: 10.1016/0005-2760(90)90028-v. View

3.
Ishidate K, Nakazawa Y . Choline/ethanolamine kinase from rat kidney. Methods Enzymol. 1992; 209:121-34. DOI: 10.1016/0076-6879(92)09016-v. View

4.
PORTER T, Kent C . Choline/ethanolamine kinase from rat liver. Methods Enzymol. 1992; 209:134-46. DOI: 10.1016/0076-6879(92)09017-w. View

5.
Morrow J, Awad J, Kato T, Takahashi K, Badr K, Roberts 2nd L . Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J Clin Invest. 1992; 90(6):2502-7. PMC: 443408. DOI: 10.1172/JCI116143. View